BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity-Reference-Cited by-同舟云学术

BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity

Published:2020-12-13 Issue:1 Volume:2 Page:125-130
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Poussard Margaux¹,Philippe Laure²^ORCID,Fredon Maxime¹,Bôle‐Richard Elodie¹,Biichle Sabeha¹,Renosi Florian¹,Perrin Sophie³,Kroemer Marie³,Limat Samuel³,Bonnefoy Francis¹,Daguindau Etienne¹⁴,Deconinck Eric¹⁴^ORCID,Gruson Bérengère⁵,Saas Philippe¹,Adotévi Olivier¹⁶,Garnache‐Ottou Francine¹⁷,Angelot‐Delettre Fanny¹⁸

Affiliation:

1. INSERM EFS BFC UMR1098 RIGHT Interactions Greffon‐Hôte Tumeur/Ingénierie Cellulaire et Génique Univ. Bourgogne Franche‐Comté Besançon France

2. Service d'hématologie CH Annecy Genevois Metz‐Tessy France

3. Pharmacy Department,CHRU Besançon University Hospital of Besançon Besançon France

4. Service d'hématologie CHRU Besançon Besançon France

5. Service d'hématologie CHU Amiens Amiens France

6. Service d'oncologie médicale CHRU Besançon Besançon France

7. Laboratoire d'hématologie Etablissement Français du Sang Bourgogne Franche‐Comté Besançon France

8. Laboratoire d'Immuno‐hématologie Etablissement Français du Sang Bourgogne Franche‐Comté Besançon France

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.149

Reference15 articles.

1. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia

2. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study

3. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

4. Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity

5. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation